Omapatrilat normalizes renal function cu
β
Paloma Morazo; Lourdes A Fortepiani; M Clara OrtΓz; NoemΓ M Atucha; JoaquΓn Garc
π
Article
π
2001
π
BioMed Central
π
English
β 469 KB
## Background: The present study was designed to analyze the chronic renal response to omapatrilat, a new vasopeptidase inhibitor, in spontaneously hypertensive rats (SHR). To that end, the renal and blood pressure response to a 4-day salt loading protocol was analyzed and the respective chronic r